Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Dusheiko

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Journal of Hepatology|August 6, 2017
Hepatitis B cure: From discovery to regulatory approvalAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
The Lancet. Infectious Diseases|December 7, 2007
Therapeutic strategies in the management of patients with chronic hepatitis B virus infectionGeorge V Papatheodoridis, Spilios Manolakopoulos, Geoffrey Dusheiko, et al.
Clinical Microbiology Reviews|February 28, 2020
Hepatitis B Virus: Advances in Prevention, Diagnosis, and TherapyMindie H Nguyen, Grace Wong, Edward Gane, et al.
Journal of Medical Economics|September 17, 2013
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patientsSandrine Cure, Florence Bianic, Sandra Gavart, et al.
Journal of Hepatology|December 13, 2017
Eliminating hepatitis C within low-income countries - The need to cure genotypes 4, 5, 6Tarik Asselah, Tarek Hassanein, Imam Waked, et al.
Journal of Medical Economics|October 29, 2013
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patientsSandrine Cure, Florence Bianic, Sandra Gavart, et al.
Hepatology (Baltimore, Md.)|August 29, 2002
The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infectionEleanor Barnes, Gillian Harcourt, Dave Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
The role of cells refractory to productive infection in acute hepatitis B viral dynamicsStanca M Ciupe, Ruy M Ribeiro, Patrick W Nelson, et al.
European Journal of Immunology|May 27, 2004
Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cellsEleanor Barnes, Scott M Ward, Victoria O Kasprowicz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2008
Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotypingPatrick T F Kennedy, Natalie Phillips, Jaya Chandrasekhar, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Journal of Hepatology|August 6, 2017
Hepatitis B cure: From discovery to regulatory approvalAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
The Lancet. Infectious Diseases|December 7, 2007
Therapeutic strategies in the management of patients with chronic hepatitis B virus infectionGeorge V Papatheodoridis, Spilios Manolakopoulos, Geoffrey Dusheiko, et al.
Clinical Microbiology Reviews|February 28, 2020
Hepatitis B Virus: Advances in Prevention, Diagnosis, and TherapyMindie H Nguyen, Grace Wong, Edward Gane, et al.
Journal of Medical Economics|September 17, 2013
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patientsSandrine Cure, Florence Bianic, Sandra Gavart, et al.
Journal of Hepatology|December 13, 2017
Eliminating hepatitis C within low-income countries - The need to cure genotypes 4, 5, 6Tarik Asselah, Tarek Hassanein, Imam Waked, et al.
Journal of Medical Economics|October 29, 2013
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patientsSandrine Cure, Florence Bianic, Sandra Gavart, et al.
Hepatology (Baltimore, Md.)|August 29, 2002
The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infectionEleanor Barnes, Gillian Harcourt, Dave Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
The role of cells refractory to productive infection in acute hepatitis B viral dynamicsStanca M Ciupe, Ruy M Ribeiro, Patrick W Nelson, et al.
European Journal of Immunology|May 27, 2004
Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cellsEleanor Barnes, Scott M Ward, Victoria O Kasprowicz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2008
Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotypingPatrick T F Kennedy, Natalie Phillips, Jaya Chandrasekhar, et al.
Pageof 12